Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Han-Hua Yu"'
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Background Despite many studies suggesting an association between serum IgG4 and IgG4-related diseases (IgG4-RD), the evidence of the utility of serum IgG4 titres in differentiating between IgG4-RD and non-IgG4-RD remains uncertain.Methods The primar
Externí odkaz:
https://doaj.org/article/4e287480edff476d8cbbaa93437a3927
Autor:
Han-Hua Yu, Pao-Feng Hsieh, Szu-Wei Huang, Tien-Ming Chan, Pao-Lien Tai, Shih-Ting Yang, Kuang-Hui Yu
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 3027 (2023)
Antinuclear antibodies (ANAs) are essential diagnostic markers in systemic autoimmune rheumatic diseases. Among the 30 ANA patterns, homogeneous (AC-1) and dense fine speckled (AC-2) should be focused on owing to their somewhat indistinct presentatio
Externí odkaz:
https://doaj.org/article/961355eb90594bb58f0b186062e23a5d
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Few studies have evaluated the association between the risk of coronary artery disease (CAD) and the use of Chinese herbal products (CHP) in patients with rheumatoid arthritis (RA). This study investigated the risk of CAD among pa
Externí odkaz:
https://doaj.org/article/c868b8567b0d4fe69fef6f4f35385a85
Autor:
Han-Hua Yu, Chia-Jung Hsieh
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that involves multiple systems and organs. Advanced conventional treatment does not appear to markedly reduce the risk of cardiovascular disease (CVD) among patients with SLE
Externí odkaz:
https://doaj.org/article/00f796b323014b69aaa4961968f7fdd8
Autor:
Han-Hua Yu, Jing-Ren Jeng
Publikováno v:
Tzu-Chi Medical Journal, Vol 29, Iss 1, Pp 50-54 (2017)
We report a case of acute pulmonary embolism with hemodynamic instability diagnosed by a computed tomography pulmonary angiogram. The patient developed pulseless electrical activity during systemic thrombolytic therapy with recombinant tissue plasmin
Externí odkaz:
https://doaj.org/article/0b57c80a808c4f1c8e8b55e8d652bea3
Publikováno v:
RMD Open; Dec2023, Vol. 9 Issue 4, p1-8, 8p
Autor:
Tien-Ming Chan, Chiao-En Wu, Han-Hua Yu, Chao-yang Hsiao, Tse-Hsuan Su, Chun-Bing Chen, Meng-Jiung Chiou, Kuang-Hui Yu, Chang-Fu Kuo
Publikováno v:
Rheumatology.
Objective To provide better preconceptional and prenatal counselling to patients with sjögren syndrome (SS). Methods In total, 2 100 143 pregnancies between 2004 and 2014 were identified in the Taiwan National Health Insurance database and birth reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4432f9ac0230db992269185b591f2b3f
https://doi.org/10.1093/rheumatology/keac711
https://doi.org/10.1093/rheumatology/keac711
Autor:
Sing-Ya Chang, Chih-Chun Lee, Ming-Ling Chang, Wen-Chieh Teng, Chao-Yang Hsiao, Han-Hua Yu, Meng-Ju Hsieh, Tien-Ming Chan
Publikováno v:
Journal of Clinical Medicine. 11:6887
Kimura disease (KD) is a rare, chronic proliferative condition presenting as a subcutaneous mass predominantly located in the head and neck region; it is characterized by eosinophilia and elevated serum IgE levels. IgG4-related disease (IgG4RD) is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12160f2b770159038e364b6acb64ffc5
https://doi.org/10.3390/jcm11236887
https://doi.org/10.3390/jcm11236887
Publikováno v:
BMC Complementary Medicine and Therapies
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-10 (2020)
Background Few studies have evaluated the association between the risk of coronary artery disease (CAD) and the use of Chinese herbal products (CHP) in patients with rheumatoid arthritis (RA). This study investigated the risk of CAD among patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2b646f4eb079fd23d51de8e1cf3fdaf
https://doi.org/10.1186/s12906-020-02894-8
https://doi.org/10.1186/s12906-020-02894-8
Publikováno v:
Medicine. 101:e28612
Previous treatment for macrophage activation syndrome (MAS) includes high-dose intravenous methylprednisolone along with intravenous immunoglobulin G. If MAS worsened, second-line therapy consisted of anakinra; if the disease remained refractory, thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a1e158a9e88ecdd635633e3c1090ce
https://doi.org/10.1097/md.0000000000028612
https://doi.org/10.1097/md.0000000000028612